NGHLF (Nightingale Health) Research & Development: $0.00 Mil (TTM As of Dec. 2025)


NGHLF Nightingale Health PLC NGHLF
52 GF Score
Price $1.19
GF Value $2.64
Valuation Possible Value Trap
! 6 Warning Signs
View Full Analysis

What is Nightingale Health Research & Development?

Nightingale Health NGHLF 52 Research & Development is $0.00 Mil as of Dec. 2025. GuruFocus rates NGHLF with a GF Score™ of 52/100 and a GF Value™ of $2.64 (Possible Value Trap). The stock has 6 warning signs investors should review.

Research & Development is the aggregate amount of research and development expenses during the year. Nightingale Health's Research & Development for the six months ended in Dec. 2025 was $0.00 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 was $0.00 Mil.

Nightingale Health  (OTCPK:NGHLF) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Nightingale Health Research & Development Related Terms

Nightingale Health Research & Development Historical Data

* Premium members only.

The historical data trend for Nightingale Health's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Nightingale Health Research & Development Chart

Nightingale Health Annual Data
Trend Jun19 Jun20 Jun21 Jun22 Jun23 Jun24 Jun25
Research & Development
Get a 7-Day Free Trial 0.42 1.30 0.65 0.23 0.14

Nightingale Health Semi-Annual Data
Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
NGHLF
52GF Score
Nightingale Health PLC NGHLF
Research & Development is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Nightingale Health Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Dec. 2025 adds up the semi-annually data reported by the company within the most recent 12 months, which was $0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Research & Development →
What does a Research & Development of $0.00 Mil mean?
Nightingale Health (NGHLF) has a Research & Development of $0.00 Mil as of Dec. 2025. Research and development expense is the total cost for research and development activities. View historical data on Nightingale Health and its competitors.
Is Nightingale Health's Research & Development too high?
Nightingale Health's current Research & Development is $0.00 Mil. Overall, Nightingale Health has a GF Score™ of 52/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Nightingale Health's Research & Development compare to VEEV and BTSG?
Nightingale Health's Research & Development of $0.00 Mil can be compared against companies in the Healthcare Providers & Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Research & Development for a Healthcare Providers & Services company?
A good Research & Development depends on the Healthcare Providers & Services industry context. However, Research & Development should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Research & Development mean?
A high Research & Development can signal that a stock is expensive relative to its fundamentals. Research and development expense is the total cost for research and development activities. View historical data on Nightingale Health and its competitors. Nightingale Health's current Research & Development is $0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nightingale Health stock overvalued right now?
Based on GuruFocus' analysis, Nightingale Health (NGHLF) is currently considered Possible Value Trap. The stock's GF Value™ is $2.64, compared to a current price of $1.19 — trading 54.9% below its estimated fair value. The current Research & Development is $0.00 Mil. Nightingale Health's overall GF Score™ is 52/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Research & Development calculated?
Research & Development is calculated from a company's financial statements. For Nightingale Health (NGHLF), the current Research & Development is $0.00 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Nightingale Health (NGHLF) Overvalued in 2026?

Based on GuruFocus' analysis, Nightingale Health stock appears to be undervalued. The current stock price of $1.19 is trading 54.9% below its estimated GF Value™ of $2.64. GuruFocus considers Nightingale Health to be Possible Value Trap.

Key valuation signals for NGHLF:

  • Research & Development: $0.00 Mil
  • GF Value™: $2.64 vs. price of $1.19 (54.9% below fair value)
  • GF Score™: 52/100 with 6 warning signs

No single metric tells the full story. See the NGHLF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Nightingale Health Business Description

Other Exchanges HEALTH:Finland7XE:Germany
Address Mannerheimintie 164a, Helsinki, FIN, 00300
Nightingale Health PLC offers a health data platform that detects disease risks. The Health Data Platform empowers individuals to take actions to prevent diseases by allowing them access to disease risk information. With its Health Data Platform, the company connects the services of healthcare actors with the preventative health needs of individuals. The company operates in Finland, Japan, the United Kingdom, Singapore, and the USA.
52GF Score

Get the complete analysis for NGHLF

Research & Development is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$1.19
Price
$2.64
GF Value